Ironwood Pharmaceuticals
IRWD
IRWD
254 hedge funds and large institutions have $1.74B invested in Ironwood Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 107 increasing their positions, 79 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 250 → 254 (+4)
2.62% less ownership
Funds ownership: 109.41% → 106.78% (-2.6%)
14% less capital invested
Capital invested by funds: $2.03B → $1.74B (-$290M)
Holders
254
Holding in Top 10
2
Calls
$412K
Puts
$30K
Top Buyers
| 1 | +$18.8M | |
| 2 | +$12M | |
| 3 | +$10M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.96M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.72M |
Top Sellers
| 1 | -$75.3M | |
| 2 | -$27.4M | |
| 3 | -$17.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$14.2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.34M |